MedTrace Logo

Neocortical Epilepsies - Do They Progress?

NCT00610558 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2019-11-20

Study results available
· View outcomes & findings →

Summary

This study will use MRI and PET scan to compare the brain imaging results between epilepsy patients and normal healthy controls, also to study changes in 3 years.

Conditions

Interventions

DEVICE

Arm 1: Juvenile Myoclonic Epilepsy

Positron emission tomography (PET) fluorodeoxyglucose (FDG) (10 mCi) and MRI

DEVICE

Arm 2: Frontal Lobe Epilepsy

Positron emission tomography (PET) fluorodeoxyglucose (FDG) (10 mCi) and MRI

DEVICE

Arm 3: Normal Controls

Positron emission tomography (PET) fluorodeoxyglucose (FDG) (10 mCi) and MRI

Sponsors & Collaborators

  • University of California, Irvine

    lead OTHER

Principal Investigators

  • Min-Ying Su, PhD · University of California, Irvine

Study Design

Allocation
NON_RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2003-07-31
Primary Completion
2009-06-30
Completion
2010-09-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00610558 on ClinicalTrials.gov